ArticleJournal of experimental & clinical cancer research : CR2019

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer.

María Del Mar Noblejas-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.